¿ä·Î °¨¿° °Ë»ç ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Urinary Tract Infection Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1801912
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 134 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,801,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,484,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,710,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¿ä·Î °¨¿° °Ë»ç ½ÃÀåÀº 2024³â 10¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, CAGR 6.2%·Î ¼ºÀåÇÏ¿© 2034³â 19¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÀÌ ½ÃÀåÀº ¿ä·Î °á¼®ÀÇ ¼¼°è ºÎ´ã Áõ°¡, ¿ø³» °¨¿° Áõ°¡, ½ÅÈï ±¹°¡ÀÇ ´ç´¢º´ À¯º´·ü Áõ°¡, Çõ½ÅÀûÀÎ Áø´Ü ¼Ö·ç¼Ç Ãâ½Ã µî ¿©·¯ ÇÙ½É ¿äÀÎÀ¸·Î °ß°íÇÏ°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´Àº ºñ´¢±â °¨¿°¿¡ °É¸®±â ½±±â ¶§¹®¿¡ Àü ¼¼°èÀûÀ¸·Î ´ç´¢º´ ȯÀÚ ¼ö°¡ Áõ°¡Çϰí Àû½Ã¿¡ È¿À²ÀûÀÎ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¿ä·Î °¨¿° °Ë»ç Market-IMG1

¿ä·Î °¨¿° °Ë»ç´Â ¹æ±¤, ¿äµµ, ½ÅÀå ¹× ¿ä°üÀ» ºñ·ÔÇÑ ºñ´¢±â °èÅëÀÇ ´Ù¾çÇÑ ºÎÀ§¿¡¼­ °¨¿°À» °¨ÁöÇÏ´Â µ¥ µµ¿òÀ̵Ǵ ÀÓ»ó °úÁ¤ÀÔ´Ï´Ù. Á¶±â Áø´Ü ¹× Á¤È®ÇÑ Ä¡·á¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °Ç°­ °ü¸® Á¦°ø¾÷ü´Â ȯÀÚÀÇ È¿°úÀûÀÎ °á°ú¸¦ Áö¿øÇÏ´Â °í±Þ °Ë»ç ŰƮ¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. Áø´Ü¹ýÀÇ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀº ¹«Áõ»ó °¨¿°ÀÇ ¹®Á¦¸¦ Á¶±â¿¡ ÇØ°áÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÌ·¯ÇÑ ±â¼úÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÃËÁøÇÏ°í °Ç°­ °ü¸® ½Ã¼³ Àü¹Ý¿¡ °ÉÃÄ ½ÃÀå È®´ë¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ±Ý¾× 10¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 19¾ï ´Þ·¯
CAGR 6.2%

¼Òº¯ °Ë»ç ºÐ¾ß´Â 2024³â 4¾ï 9,410¸¸ ´Þ·¯·Î ÇÕ¸®ÀûÀÎ °¡°Ý, °¡¿ë¼º ¹× Áø´Ü Á¤È®µµ·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼Òº¯ °Ë»ç´Â ¹ÚÅ׸®¾ÆÀÇ Á¸À縦 °ËÃâÇϰí ÈÄ¼Ó ÀÓ»ó ÆÇ´ÜÀ» ¾È³»Çϱâ À§ÇÑ ¿¹ºñ °Ë»ç·Î ¿©ÀüÈ÷ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ±â¼¼´Â »ý¸®Àû º¯È­¿Í Ä«Å×ÅÍ ¹× ±âŸ °³ÀÔ ¼ö´ÜÀÇ »ç¿ë Áõ°¡·Î ÀÎÇØ ¿ä·Î °á¼® À§ÇèÀÌ ³ô¾ÆÁö´Â ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¹æ±¤¿° ºÎ¹®Àº 2024³â¿¡ 52.1%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹æ±¤¿°Àº °¡Àå ±¤¹üÀ§ÇÑ ¿ä·Î °á¼®ÀÇ ÇÏÀ§ À¯ÇüÀÌ¸ç »ý¹°ÇÐÀû ¿äÀÎÀ¸·Î ¿©¼º¿¡°Ô Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ȯÀÚÀÇ ºó¹øÇÑ Àç¹ßÀº °è¼ÓÇØ¼­ Áø´Ü °Ë»çÀÇ ¹Ýº¹À» ÃËÁøÇÏ°í °ü·Ã °Ë»ç ¼Ö·ç¼ÇÀÇ »ç¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ¿Í º´ÇàÇÏ¿© ¹æ±¤¿°ÀÇ Ãʱâ Áõ»ó¿¡ ´ëÇÑ »çȸÀû ÀÎÁöÀÇ Çâ»óÀº ±³À°ÀûÀÎ °Ç°­ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖÀ¸¸ç, ´õ ¸¹Àº °³ÀÎÀÌ °Ë»ç¸¦ ¹Þµµ·Ï Ã˱¸Çϰí ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ ¿ä·Î °¨¿° °Ë»ç ½ÃÀåÀº 2024³â¿¡ 36.4%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â Áö¿ªÀÇ °ß°íÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó, °í±Þ ÀÇ·á Áø´ÜÀÇ Á¶±â µµÀÔ, ¹Ì±¹°ú ij³ª´ÙÀÇ ¿ä·Î °á¼® ȯÀÚ ¼ö Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ƯÈ÷ ³ëÀÎ, ¿©¼º, Àå±âÀûÀÎ °Ç°­»óÅ¿¡ ÀÖ´Â »ç¶÷µé »çÀÌ¿¡¼­ ¿ä·Î°á¼®Áõ·Ê°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ÀÌ Áö¿ª¿¡¼­ ¿ä·Î°á¼®°Ë»ç»ê¾÷ÀÇ Áö¼ÓÀûÀÎ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿ä·Î °¨¿° °Ë»ç ¼¼°è ½ÃÀå¿¡¼­ Ȱ¾àÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Siemens Health Inners, Acon Laboratories, Cardinal Health, Quest Diagonistics, Thermo Fisher Scientific ¸¯, ¹ÙÀÌ¿À ·¡µå ¶óº¸¶óÅ丮Áî, ¾Öº¿ ¶óº¸¶óÆ®¸®Áî, F. È£ÇÁ¸¸ ¶ó ·Î½´, ·¦ÄÚÇÁ, ·£µå½º ¶óº¸¶óÅ丮Áî, Æ÷Ä¿½º ¶óº¸¶óÅ丮Áî, ¸ÇÄ«ÀÎµå µîÀÌ ÀÖ½À´Ï´Ù. ¿ä·Î °¨¿° °Ë»ç ºÐ¾ßÀÇ ´ë±â¾÷Àº ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ ±»È÷±â À§ÇØ ÀÚµ¿È­¿Í µðÁöÅÐ ÅëÇÕ¿¡ ÀÇÇÑ Áø´Ü Á¤¹ÐµµÀÇ Çâ»ó°ú °Ë»ç ¼Ò¿ä ½Ã°£ÀÇ ´ÜÃà¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Á¦°ø¾÷ü ¹× Áø´Ü ½ÇÇè½Ç°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº Á¦Ç° °¡¿ë¼º°ú °í°´ µµ´Þ¹üÀ§¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â ¶ÇÇÑ Á¶±â ¹ß°ßÀ» Áö¿øÇÏ´Â ½Å¼Ó °Ë»ç ŰƮ ¹× Æ÷ÀÎÆ® ¿Àºê Äɾî Àåºñ °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ß¿¡ Àû±ØÀûÀ¸·Î ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¹«Áõ»óÀÎ °æ¿ì¿¡µµ ½Å·Ú¼ºÀÌ ³ôÀº °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â °í°¨µµ ºÐ¼®À̳ª ºÐÀÚ°Ë»çÀÇ °³¹ßÀÌ Á߽õǰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : °Ë»ç À¯Çüº°, 2021³â-2034³â

Á¦6Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : °Ë»ç ŰƮ À¯Çüº°, 2021³â-2034³â

Á¦7Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ¿ëµµº°, 2021³â-2034³â

Á¦8Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2034³â

Á¦9Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Áö¿ªº°, 2021³â-2034³â

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Urinary Tract Infection Testing Market was valued at USD 1 billion in 2024 and is estimated to grow at a CAGR of 6.2% to reach USD 1.9 billion by 2034. This market is expanding steadily, driven by several core factors such as the rising global burden of UTIs, the growing number of hospital-acquired infections, increased diabetes prevalence in developing countries, and the launch of innovative diagnostic solutions. As diabetes makes individuals more susceptible to urinary infections, the rising number of diabetic patients worldwide is fueling greater demand for timely and efficient diagnostic tools.

Urinary Tract Infection Testing Market - IMG1

UTI testing is a clinical process that helps detect infections in various parts of the urinary system, which includes the bladder, urethra, kidneys, and ureters. The growing need for early diagnosis and accurate treatment is pushing healthcare providers to adopt advanced testing kits that support effective patient outcomes. Continuous innovation in diagnostic methods is helping address the challenge of symptomless infections in early stages, promoting the wider adoption of these technologies and boosting market expansion across healthcare facilities.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1 Billion
Forecast Value$1.9 Billion
CAGR6.2%

The urinalysis segment was valued at USD 494.1 million in 2024 due to its affordability, availability, and diagnostic precision. Urinalysis remains the preferred preliminary test for detecting bacterial presence and guiding subsequent clinical decisions. The segment's momentum is further accelerated by the growing elderly population, who face a higher risk of UTIs because of physiological changes and increased use of catheters and other interventions.

The cystitis segment held a 52.1% share in 2024. Cystitis is the most widespread UTI subtype, largely impacting women due to biological factors. Frequent recurrence among patients continues to drive repeat diagnostic testing, increasing the uptake of related testing solutions. In parallel, improved public awareness around early symptoms of cystitis, supported by educational health initiatives, is encouraging more individuals to seek testing, further accelerating segment growth.

North America Urinary Tract Infection Testing Market held a 36.4% share in 2024. This leadership is attributed to the region's robust healthcare infrastructure, early adoption of advanced medical diagnostics, and a growing UTI patient population in both the US and Canada. Rising UTI cases-particularly among older adults, women, and individuals with long-term health conditions-are contributing to the sustained expansion of the UTI testing industry in the region.

Key companies active in the Global Urinary Tract Infection Testing Market include Siemens Healthineers, ACON Laboratories, Cardinal Health, Quest Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche, Labcorp, Randox Laboratories, Focus Laboratories, and Mankind. To solidify their market position, leading players in the urinary tract infection testing space are focusing on advancing diagnostic accuracy and speeding up testing turnaround times through automation and digital integration. Strategic partnerships with healthcare providers and diagnostic labs are expanding product availability and customer reach. Companies are also heavily investing in R&D to develop rapid testing kits and point-of-care devices that support early-stage detection. Emphasis is being placed on developing high-sensitivity assays and molecular tests that deliver reliable results even in asymptomatic cases.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Test Kit Type, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â